Area of research
Infectious Diseases · Emergency Medicine
Research interest
Research interests include Poisoning and overdose treatments, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, and Pharmacovigilance and Adverse Drug Reactions.
Clinical effects of cannabis compared to synthetic cannabinoid receptor agonists (SCRAs): a retrospective cohort study of presentations with acute toxicity to European hospitals between 2013 and 2020
Neutralization, effector function and immune imprinting of Omicron variants
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
Broad betacoronavirus neutralization by a stem helix–specific human antibody
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Seizures as a complication of recreational drug use: Analysis of the Euro-DEN Plus data-set
Risk of Seizures Associated with Antidepressant Use in Patients with Depressive Disorder: Follow-up Study with a Nested Case–Control Analysis Using the Clinical Practice Research Datalink
Angiotensin II antagonists – an assessment of their acute toxicity